... and continued with a panel exploring the evolving investment landscape in longevity, examining how strategic funding can accelerate advancements in biotech, regenerative medicine and interventions for age-related diseases. https://longevity.technology/news/global-investment-leaders-weigh-in-on-the-future-of-healthspan/